Explore 3 Stock Ideas & Industry Insights Download Free Report

Medibank Private Ltd

Financial Services AU MPL

4.97AUD
0.01(0.20%)

Last update at 2026-06-12T06:10:00Z

Day Range

4.945.03
LowHigh

52 Week Range

4.065.10
LowHigh

Fundamentals

  • Previous Close 4.96
  • Market Cap13329.38M
  • Volume4946074
  • P/E Ratio28.47
  • Dividend Yield3.82%
  • EBITDA722.20M
  • Revenue TTM8770.20M
  • Revenue Per Share TTM3.18
  • Gross Profit TTM 1927.20M
  • Diluted EPS TTM0.17

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 728.80M 711.70M 727.10M 560.00M 632.30M
Minority interest -8.50000M -3.90000M - - -
Net income 500.80M 492.50M 511.10M 393.90M 441.20M
Selling general administrative 1054.80M 754.60M 671.00M 666.10M 664.50M
Selling and marketing expenses - 172.20M 115.50M 85.90M 81.40M
Gross profit 8556.30M 8018.30M 7499.30M 7092.40M 7011.00M
Reconciled depreciation 96.00M 89.40M 118.40M 115.00M 82.70M
Ebit - 717.10M 608.70M 445.00M 549.60M
Ebitda 750.80M 806.50M 727.10M 560.00M 632.30M
Depreciation and amortization - 89.40M 118.40M 115.00M 82.70M
Non operating income net other - - - - -
Operating income 7899.70M 7001.00M 608.70M 445.00M 549.60M
Other operating expenses 656.60M 619.50M 6772.20M 6532.40M 6378.70M
Interest expense 11.00M 5.40M 1.80M 2.40M 2.40M
Tax provision 219.50M 215.30M 216.00M 166.10M 191.10M
Interest income 144.40M 131.40M 3.20M 17.90M 17.70M
Net interest income -11.00000M -5.40000M -1.80000M -2.40000M -2.80000M
Extraordinary items - - - - 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 219.50M 215.30M 216.00M 166.10M 191.10M
Total revenue 8556.30M 8018.30M 7499.30M 7092.40M 7011.00M
Total operating expenses 656.60M 1017.30M 6766.00M 6542.30M 6397.10M
Cost of revenue - -8.10000M - - -
Total other income expense net -7170.90000M -6289.30000M 174.30M 248.30M 221.10M
Discontinued operations - - - - -
Net income from continuing ops 509.30M 496.40M 511.10M 393.90M 441.20M
Net income applicable to common shares 500.80M 492.50M 511.10M 393.90M 441.20M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 4700.30M 4685.40M 4388.80M 4552.80M 3923.80M
Intangible assets 157.50M - 123.60M 127.80M 140.80M
Earning assets - - - - -
Other current assets - 3778.70M 42.70M 2737.10M 1978.70M
Total liab 2364.20M 2380.30M 215.70M 2607.20M 2017.70M
Total stockholder equity 2335.90M 2305.70M 2084.40M 1945.60M 1906.10M
Deferred long term liab - - - - -
Other current liab - 85.10M -215.70000M -241.40000M -239.90000M
Common stock - 85.00M 85.00M 85.00M 85.00M
Capital stock 85.00M - 85.00M 85.00M 85.00M
Retained earnings 2223.50M 2068.40M 1971.50M 1834.90M 1798.80M
Other liab - - 177.30M 120.50M 97.10M
Good will 342.40M 323.70M 204.50M 204.50M 204.50M
Other assets - 0.00000M 3490.50M 3452.50M 2724.00M
Cash 648.60M 691.00M 420.60M 596.70M 671.70M
Cash and equivalents - - 420.60M 596.70M 671.70M
Total current liabilities - 2000.30M 215.70M 241.40M 239.90M
Current deferred revenue - 48.70M - - -
Net debt - -472.70000M -420.60000M -596.70000M -671.70000M
Short term debt - 66.60M 0.00000M 0.00000M 0.00000M
Short long term debt 35.00M - - - -
Short long term debt total - 218.30M - - 65.30M
Other stockholder equity - - -2056.50000M -1919.90000M -1883.80000M
Property plant equipment - - 70.50M 88.40M 101.70M
Total current assets - 3778.70M 420.60M 596.70M 671.70M
Long term investments 264.30M - 392.10M 338.30M 343.80M
Net tangible assets - - 1756.30M 1613.30M 1560.80M
Short term investments 225.30M 3048.20M 274.50M 234.60M 266.70M
Net receivables 66.40M - 248.10M 225.40M 215.90M
Long term debt - - - - -
Inventory - - - -3197.10000M -2461.30000M
Accounts payable 205.90M 1799.90M 215.70M 241.40M 239.90M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 152.30M 27.90M 25.70M 22.30M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - -2858.80000M -477.70000M -503.60000M -528.10000M
Deferred long term asset charges - - - - -
Non current assets total - 906.70M 477.70M 503.60M 528.10M
Capital lease obligations 174.00M - - - -
Long term debt total - - 24.40M 46.70M 65.30M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments 110.50M -110.80000M 58.50M -602.70000M -284.10000M
Change to liabilities - - 99.20M 14.50M 31.30M
Total cashflows from investing activities 110.50M -110.80000M 58.50M -623.60000M -306.10000M
Net borrowings - -1.30000M -39.70000M -38.80000M -37.00000M
Total cash from financing activities -533.80000M -487.30000M -419.10000M -399.90000M -375.80000M
Change to operating activities - - -180.50000M 282.80M 71.40M
Net income 500.80M 492.50M 511.10M 393.90M 441.20M
Change in cash -42.40000M 270.40M -176.10000M -75.00000M -199.70000M
Begin period cash flow 691.00M 420.60M 596.70M 671.70M 871.40M
End period cash flow 648.60M 691.00M 420.60M 596.70M 671.70M
Total cash from operating activities 380.90M 868.50M 184.50M 948.50M 482.20M
Issuance of capital stock - - - - -
Depreciation 96.00M 89.40M 40.70M 41.20M 45.10M
Other cashflows from investing activities 120.10M 64.50M 100.40M 14.20M 13.10M
Dividends paid 473.70M 426.90M 374.50M 358.00M 333.20M
Change to inventory - - - - -
Change to account receivables -20.80000M 9.90M -22.00000M -11.10000M -8.80000M
Sale purchase of stock -6.40000M -7.50000M -4.90000M -3.10000M -5.60000M
Other cashflows from financing activities -6.90000M -51.60000M -39.70000M -38.80000M -37.00000M
Change to netincome - - -126.90000M 30.20M -111.00000M
Capital expenditures 11.20M 57.60M 41.90M 35.10M 35.10M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -64.30000M 330.20M -22.00000M -11.10000M -8.80000M
Stock based compensation 8.50M 3.30M 6.70M 5.90M 5.20M
Other non cash items -160.10000M -46.90000M -367.30000M 513.40M -4.10000M
Free cash flow 369.70M 810.90M 142.60M 913.40M 447.10M

Peer Comparison

Sector: Financial Services Industry: Insurance - Specialty

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
MPL
Medibank Private Ltd
0.01 0.20% 4.97 28.47 18.35 1.52 5.70 1.50
NHF
NIB Holdings Ltd
0.01 0.14% 6.99 17.23 14.31 0.90 2.97 0.93
HLI
Helia Group Ltd
-0.02 0.40% 4.93 5.62 6.69 2.86 1.33 2.74

Reports Covered

Stock Research & News

Profile

Medibank Private Limited provides private health insurance in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services comprising dental, optical, and physiotherapy, as well as offers health insurance products to overseas visitors and students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth and primary care services to government and corporate customers; and distributes travel, life, and pet insurance products. It underwrites and distributes private health insurance policies under the Medibank and ahm brands for resident and nonresident customers. The company was founded in 1976 and is based in Docklands, Australia.

Medibank Private Ltd

695 Collins Street, Docklands, VIC, Australia, 3008

Key Executives

Name Title Year Born
Mr. David Koczkar B.Com., BCom, MAICD, PGDipFinance CEO, MD & Director 1973
Mr. Mark Rogers B.Sc., BEng (Hons), BSc Group Exec. of CFO & Group Strategy NA
Dr. Andrew Wilson FACHSE, FRANZCP, M.M., MBBS, MM Group Exec. & CEO of Amplar Health NA
Mr. Milosh Milisavljevic Group Exec. of Customer Portfolios NA
Mr. John Goodall B.Sc., BSc (Hons) Group Exec. of Technology & Operations NA
Mr. Peter Kopanidis Sr. Exec. of Corp. Fin. NA
Colette Campbell Sr. Exec. of Investor Relations NA
Ms. Mei Ramsay B.A., BA, L.L.B., L.L.M., LLB, LLM Group Exec. of Legal, Governance & Compliance and Company Sec. NA
Emily Ritchie Sr. Exec. of External Affairs NA
Ms. Kylie Bishop B.A., BA (Hons) Psy, MOrgPsych Group Exec. of People, Culture & Sustainability NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.